Sanofi Aktie

45,60 EUR +0,20 EUR +0,44 %

10:25:20

STU

53,26 USD +0,18 USD +0,34 %

nachbörslich00:50:02

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

KGV20,07Div. Rendite3,34%

WKN662283

ISINUS80105N1054

SymbolSNY

Sanofi Aktien News

Sortieren:Datum Meistgelesen

21.10.24Financial TimesSanofi deal offers only partial headache relief

21.10.24BenzingaSanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business

21.10.24Business TimesSanofi enters exclusive talks with CD&R for Opella sale

21.10.24GlobeNewswirePress Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare

20.10.24Financial TimesFrance takes stake in Sanofi unit as part of €16bn sale to CD&R

17.10.24Financial TimesSanofi joins rivals investing in nuclear cancer treatment

17.10.24GlobeNewswirePress Release: Sanofi and Orano join forces to develop next-generation radioligand medicines

16.10.24PR NewswireFLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals

15.10.24GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - September 2024

15.10.24BenzingaSanofi Might Face Political Hurdles In $16B Consumer Pharma Unit Sale To US Private Equity CD&R

15.10.24Financial TimesFrance warns it could block €15.5bn Sanofi consumer health deal

14.10.24ZacksShould Value Investors Buy Sanofi (SNY) Stock?

14.10.24Business TimesFrance seeks job guarantees from Sanofi over Doliprane painkiller production

11.10.24MarketWatchSanofi in talks to sell consumer healthcare business that makes Dulcolax

11.10.24GlobeNewswirePress Release: Sanofi in discussions to sell a controlling stake in Opella

10.10.24Financial TimesCD&R beats rivals in pursuit of €15.5bn Sanofi consumer health unit

09.10.24GlobeNewswirePress Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants

08.10.24ZacksZacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer

04.10.24BenzingaGSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report

04.10.24BenzingaSanofi Sells Global Rights To Rare Autoimmune Drug Enjaymo For $825M Upfront To Italian Firm Recordati

30.09.24ZacksSanofi, Regeneron's Dupixent Gets FDA Approval for COPD

27.09.24GlobeNewswirePress Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD

27.09.24GlobeNewswirePress Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD

26.09.24ZacksAre Investors Undervaluing Sanofi (SNY) Right Now?

26.09.24GlobeNewswirePress Release: Availability of the Q3 2024 Aide mémoire

24.09.24Business TimesLenders line up more than 10 billion euros for Sanofi health unit buyout

23.09.24BenzingaSanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences

21.09.24GlobeNewswirePress Release: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for trans

20.09.24GlobeNewswirePress Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

20.09.24EN, Sanofi-AventisPress Release: Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old

20.09.24GlobeNewswirePress Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study

20.09.24EN, Sanofi-AventisPress Release: Tolebrutinib demonstrated a 31% delay in time to onset of confirmed disability progression in non-relapsing secondary progressive multiple sclerosis phase 3 study

19.09.24ZacksSanofi Stock Up Almost 23% in 3 Months: Buy, Sell or Hold?

16.09.24GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - August 2024

12.09.24GlobeNewswirePress Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers

12.09.24EN, Sanofi-AventisPress Release: Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers

11.09.24ZacksSanofi, Regeneron's Dupixent Meets Late-Stage Urticaria Study Goals

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.